Potassium phosphate and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium phosphate (potassium) and Tacrolimus (tacrolimus). Common drug interactions include diarrhoea among females and appendicitis among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium phosphate and Tacrolimus. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium phosphate?

Potassium phosphate has active ingredients of potassium. eHealthMe is studying from 578 Potassium phosphate users. Check the latest studies of Potassium phosphate.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.



On Jul, 16, 2026

30 people who take Potassium phosphate and Tacrolimus together, and have interactions are studied.

Potassium phosphate and Tacrolimus drug interactions.

What are the common drug interactions of Potassium Phosphate and Tacrolimus, by gender? *:

female:

  1. Diarrhoea
  2. Hypotension (abnormally low blood pressure)
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Abdominal distension
  7. Bacteraemia (presence of bacteria in the blood)
  8. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  9. Raoultella ornithinolytica infection
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

male:

  1. Appendicitis (inflammation of the appendix)
  2. Gastritis (inflammation of stomach)
  3. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  4. Renal cyst (kidney cyst)
  5. Bartter's syndrome (inherited defect in the thick ascending limb of the loop of henle)
  6. Blood potassium increased
  7. Drug level above therapeutic
  8. Renal failure acute (rapid kidney dysfunction)
  9. Septic shock (shock due to blood infection)
  10. Abdominal distension

What are the common drug interactions of Potassium Phosphate and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

  1. Acute respiratory distress syndrome
  2. Cardiomyopathy (weakening of the heart muscle)
  3. Hepatic failure (liver failure)
  4. Pulmonary oedema (fluid accumulation in the lungs)

2-9:

  1. Hypotension (abnormally low blood pressure)
  2. Renal impairment (severely reduced kidney function)
  3. Circulatory collapse

10-19:

  1. Bartter's syndrome (inherited defect in the thick ascending limb of the loop of henle)
  2. Transplant rejection (a transplant material is not worked)

20-29:

  1. Anxiety
  2. Delirium (wild excitement)
  3. Drug level increased
  4. Insomnia (sleeplessness)
  5. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  6. Sleep disorder

30-39:

  1. Hepatic failure (liver failure)
  2. Septic shock (shock due to blood infection)
  3. Staphylococcal infection (an infection with staphylococcus bacteria)
  4. Abdominal distension
  5. Dyspnoea (difficult or laboured respiration)
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
  8. Transplant rejection (a transplant material is not worked)

40-49:

  1. Streptococcal infection

50-59:

  1. Appendicitis (inflammation of the appendix)
  2. Gastritis (inflammation of stomach)
  3. Hepatic vein thrombosis (obstruction in the veins of the liver caused by a blood clot)
  4. Oesophageal candidiasis (fungal infection of oesophagus)
  5. Postoperative wound infection
  6. Pyrexia (fever)
  7. Non-hodgkin's lymphoma recurrent (reoccurrence malignant (cancer) cells form in the lymph system)
  8. Asthenia (weakness)
  9. Diarrhoea
  10. Lung infection

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Small intestinal obstruction (blockage in small intestine)
  5. Renal failure (kidney dysfunction)
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  7. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  8. Blood potassium increased
  9. Drug level above therapeutic
  10. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 7 people, 23.33%
  2. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 7 people, 23.33%
  3. Immunodeficiency Disorders: 5 people, 16.67%
  4. Constipation: 4 people, 13.33%
  5. Rickets (softening of bones): 4 people, 13.33%
  6. Pain: 4 people, 13.33%
  7. High Blood Pressure: 4 people, 13.33%
  8. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 4 people, 13.33%
  9. Urinary Tract Infection: 3 people, 10.00%
  10. Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium phosphate and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium phosphate and Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium phosphate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tacrolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium and tacrolimus (the active ingredients of Potassium phosphate and Tacrolimus, respectively), and Potassium phosphate and Tacrolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: